Abstract:Abstract Background Diabetes mellitus (DM) is common in patients with heart failure (HF). But the harmful effect of DM on mortality in patients with HF remains controversial. Furthermore, it seems that no consistent conclusion on whether chronic kidney disease (CKD) modifies the relationship of DM and poor prognosis in patients with HF. Methods We analyzed the individuals with heart failure with reduced ejection fraction (HFrEF) from the Cardiorenal ImprovemeNt (CIN) cohort between January 2007 to December 2018. The primary endpoint was all-cause mortality. The patients were divided into four groups (control vs. DM alone vs. CKD alone vs. DM and CKD). Multivariate Cox proportional hazards analysis was conducted to examine the association among DM, CKD and all-cause mortality. Results There were 3,273 patients included in this study (mean age: 62.7 ± 10.9 years, 20.4% were female). During a median follow-up of 5.0 years (interquartile range: 3.0 to 7.6 years), 740 (22.6%) patients died. Patients with DM have a higher risk of all-cause mortality (HR [95% confidence interval (CI)]:1.32[1.10–1.57]) than those without DM. In patients with CKD, DM had a 61% (HR [95% CI]:1.61[1.26–2.06]) increased adjusted risk of death relative to non-DM, while in patients with non-CKD, there was no significantly difference in risk of all-cause mortality (HR [95% CI]:1.01[0.77–1.32]) between DM and non-DM (p for interaction = 0.013). Conclusions Diabetes is a potent risk factor for mortality in patients with HFrEF. Furthermore, DM had a substantially different effect on all-cause mortality depending on CKD. The association between DM and all-cause mortality was only observed in patients with CKD.

Mechanisms of Synergistic Interactions of Diabetes and Hypertension in Chronic Kidney Disease: Role of Mitochondrial Dysfunction and ER Stress

Mitochondria-Derived Reactive Oxygen Species Contribute to Synergistic Interaction of Diabetes and Hypertension in Causing Chronic Kidney Injury

Roles of Mitochondrial Dysfunction in Diabetic Kidney Disease: New Perspectives from Mechanism to Therapy

Novel Insights Into Molecular Mechanism of Mitochondria in Diabetic Cardiomyopathy

Broadening horizons: the contribution of mitochondria-associated endoplasmic reticulum membrane (MAM) dysfunction in diabetic kidney disease

Hypertension in Diabetes: An Update of Basic Mechanisms and Clinical Disease

Heart Failure in Patients with Diabetes and Chronic Kidney Disease: Challenges and Opportunities

The role of endoplasmic reticulum–mitochondria-associated membranes in diabetic kidney disease

Mitochondrial regulation of diabetic endothelial dysfunction: Pathophysiological links

Interaction of Diabetes Mellitus and Chronic Kidney Disease on Outcome in Heart Failure with Reduced Ejection Fraction

Renal Epithelial Mitochondria: Implications for Hypertensive Kidney Disease

The Diabetic Cardiorenal Nexus

Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy

Common gene signatures and molecular mechanisms of diabetic nephropathy and metabolic syndrome

Organelle dynamics of endothelial mitochondria in diabetic angiopathy

Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction

Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets

An Overview of the Posttranslational Modifications and Related Molecular Mechanisms in Diabetic Nephropathy

Mitochondrial metabolic reprogramming in diabetic kidney disease

Mitochondrial dysfunction in diabetic nephropathy: insights and therapeutic avenues from traditional Chinese medicine

Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy